21540415

Source:http://linkedlifedata.com/resource/pubmed/id/21540415

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024141, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0392347, umls-concept:C0439234, umls-concept:C0814225
pubmed:issue	17
pubmed:dateCreated	2011-5-4
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/belimumab
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1538-3598
pubmed:author	pubmed-author:MitkaMikeM
pubmed:issnType	Electronic
pubmed:day	4
pubmed:volume	305
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1754-5
pubmed:meshHeading	pubmed-meshheading:21540415-African Americans, pubmed-meshheading:21540415-Antibodies, Monoclonal, pubmed-meshheading:21540415-Clinical Trials as Topic, pubmed-meshheading:21540415-Drug Approval, pubmed-meshheading:21540415-Drug Costs, pubmed-meshheading:21540415-Humans, pubmed-meshheading:21540415-Lupus Erythematosus, Systemic, pubmed-meshheading:21540415-United States, pubmed-meshheading:21540415-United States Food and Drug Administration
pubmed:year	2011
pubmed:articleTitle	Treatment for lupus, first in 50 years, offers modest benefits, hope to patients.
pubmed:publicationType	News